“Selectivity Barriers in the Therapeutic Target Validation of β-Secretase-1 in the Pathogenesis of Alzheimer’s Disease: Review Article” (2026) Journal of Pharma Insights and Research, 4(3), pp. 066–098. doi:10.69613/jvyw7v28.